Dr. Erol Nargileci, MD

Dr. Nargileci practices at Norwalk Hospital in Norwalk, Connecticut.

Dr. Nargileci's NPI, 1235469263, was assigned on January 14, 2010. Dr. Nargileci holds Connecticut license 48998.

Dr. Nargileci's primary practice is Norwalk Hospital, at 34 Maple St, Norwalk, CT 06850 in Western Ct County. The practice phone is (203) 852-2216.

Dr. Nargileci's primary practice is Norwalk Hospital in Norwalk, Connecticut. Dr. Nargileci is also affiliated with Norwalk Hospital. The medical group on file is Danbury Medical Group. Dmand AI also links Dr. Nargileci to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nargileci practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Nargileci's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Nargileci's licenses on file in 2 states: Connecticut and Indiana.

CMS data shows 3,205 Medicare services from Dr. Nargileci across 23 procedure codes in 2024, for 1,645 Medicare patients. Medicare paid $121,335 for them.

CMS counts 1,645 Medicare patients who saw Dr. Nargileci in 2024. The largest group is 75 to 84, with 603 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nargileci's median patient age at 70, with 50% women.

In 2024, Dr. Nargileci wrote 1,233 Medicare Part D claims for 285 patients. 83% of them were for generic drugs. CMS names the drug for 1,109 of them, across 24 drugs with 11 or more claims each, at $190,840 in total drug cost. In 2023, CMS named 3,355 claims across 36 drugs.

Dr. Nargileci accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Nargileci, more than 33% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Nargileci in 2014. Dr. Nargileci's most frequent co-authors are Frederick Feit, MD, Vivian Gar-Yan Ng and Erik M. Ohman, MBCHB.

CMS Open Payments shows 340 general payments to Dr. Nargileci from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $3,112.